2022 American Transplant Congress
Inhibition of ITGB5 Protects Hepatocytes from Ischemia Reperfusion Injury
*Purpose: Liver transplantation is the best treatment option for patients with end-stage liver disease (ESLD). Despite the increasing interest to the machine reperfusion, cold preservation…2022 American Transplant Congress
Incidence of Biliary Complications at the Beginning of the Academic Year in an Academic Transplant Program
Transplant, Lahey Clinic, Burlington, MA
*Purpose: Surgery learning is based on a master-apprentice model, a learning curve is essential to measure the acquisition and improvement of surgical skills without compromising…2022 American Transplant Congress
Understanding Transplant Awareness in Pre-Kidney Transplant Recipients – Role of Surgeon Visit
Tulane University School of Medicine, New Orleans, LA
*Purpose: Education for pre-Kidney Transplant recipient candidates aims to improve their knowledge and understanding about the transplant process, outcomes and potential complications and facilitate adjustment…2022 American Transplant Congress
Preoperative Blood Pressure and Risk of Delayed Graft Function in Deceased Donor Kidney Transplantation
University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: Evaluate association between preoperative blood pressure and delayed graft function (DGF) in deceased donor kidney transplantation (DDKT)*Methods: In this single center study of adult…2022 American Transplant Congress
Efficacy and Safety of Angiotensin II Compared to Catecholamine Vasopressors as a First-Line Vasopressor for Perioperative Hypotension in Kidney Transplant Recipients
*Purpose: Perioperative use of catecholamine vasopressors (CV) in kidney transplantation (KT) have been associated with negative renal outcomes and the development of arrhythmias. A more…2022 American Transplant Congress
Comparison of Statin-Associated Adverse Events Across Different Types of Statins in Kidney Transplant Recipients
*Purpose: Statins are the third most prescribed drug class in kidney transplant (KT) recipients. Statin’s safety profile in KT recipients remains unclear, although these individuals…2022 American Transplant Congress
Donor Terminal Creatinine – Does It Matter?
*Purpose: When assessing deceased donor kidneys, the transplantation team studies several donor variables including creatinine. A creatinine that is elevated immediately prior to procurement can…2022 American Transplant Congress
A New Chapter In An Evolving Pandemic: Successful Pediatric Liver Transplantation With Covid+ Donors
*Purpose: We report the first two pediatric liver transplants utilizing allografts from COVID+ donors, infected at time of organ procurement, demonstrating a pivotal step toward…2022 American Transplant Congress
Identical Kidneys Are Discarded at Higher Rates When Labeled as High KDPI
University of Washington, Seattle, WA
*Purpose: The kidney donor risk index (KDRI) and percentile conversion kidney donor profile index (KDPI) were introduced with the Kidney Allocation System (KAS) to provide…2022 American Transplant Congress
Sodium-Glucose Co-Transporter 2 Inhibitors; Short-Term Outcome in Diabetic Kidney Transplant Recipients
*Purpose: The idea of using SGLT2i in kidney transplant recipients (KTR) is a legitimate one after the recent encouraging data for their use in other…
- « Previous Page
- 1
- …
- 36
- 37
- 38
- 39
- 40
- …
- 190
- Next Page »